R3vive vs 986 Pharmacy
Franchise Comparison 2026
FDDs: R3vive 2022, 986 Pharmacy 2026SBA 7(a) data through FY2026Updated How we score
Not like-for-like: these figures come from FDDs of different years (2022, 2026). Costs, fees and unit counts change from one filing to the next, so the older column may be out of date.
Both R3vive and 986 Pharmacy are franchises in the healthcare category. R3vive requires an investment of $262K – $669K while 986 Pharmacy requires $295K – $671K. Neither R3vive nor 986 Pharmacy makes a financial performance representation in Item 19 of its FDD — a voluntary item under the FTC Franchise Rule — so the two cannot be compared on disclosed gross sales. FranchiseVerdict rates R3vive B (Second tier) and 986 Pharmacy A (Strongest tier).
| Metric | R3vive | 986 Pharmacy |
|---|---|---|
| Verdict Grade | ||
| Investment Range | $262K – $669K | $295K – $671K |
| Franchise Fee | $75K | $50K |
| Royalty Rate | 6.0% | Continuing License Fee: $1,650 per month for the first 12 months, then $2,100 per month for the rest of the term; may be increased annually by up to 5% on July 1. No percentage-of-sales royalty. |
| Average Gross Sales (Item 19) | N/ANot disclosed | N/ANot disclosed |
| SBA Charge-Off Rate | N/A | Limited data |
| Total Units | 10 | 46 |
| Unit Growth (YoY) | +2 units | +2 units |
| Year Began Franchising | 2020 | N/A |
| FDD Year | 2022 | 2026 |
Next step
Browse free
Every brand with an FDD on file, graded, with costs, disclosed sales and SBA records. No sign-in.Pro
For advisors and lenders working across many brands; inquire by email.